Conventional treatment of hypercalcemia of malignancy

American Journal of Health-System Pharmacy

Volumn 58, Issue SUPPL. 3, 2001, Pages

  Davidson, T G ^a  

^a Clinical Pharmacy Associates Inc ^*  (United States)

Author keywords

Bisphosphonates; Calcitonin; Calcium regulators; Hypercalcemia; Neoplasms; Pamidronate disodium; Parathyroid hormones; Replacement solutions; Sodium chloride

Indexed keywords

CALCITONIN; CORTICOSTEROID; FUROSEMIDE; MITHRAMYCIN; PAMIDRONIC ACID; SODIUM CHLORIDE; ZOLEDRONIC ACID;

BONE REMODELING; BRAIN DISEASE; CALCIUM URINE LEVEL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONSCIOUSNESS DISORDER; DEHYDRATION; DIALYSIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; HYDRATION; HYPERCALCEMIA; HYPERCALCEMIA OF MALIGNANCY; KIDNEY FAILURE; METABOLIC DISORDER; ORAL REHYDRATION THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; TACHYPHYLAXIS; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0035889877     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.suppl_3.s8     Document Type: Conference Paper

References (13)

1. Acute management of cancer-related hypercalcemia
2. Overview of hypercalcemia of malignancy
3. Hypercalcemia and bone resorption in malignancy
4. Hypercalcemia
5. Hypercalcemia of malignancy
6. Hypercalcemia of malignancy: A review of advances in pathophysiology
7. Hypercalcemic crisis
8. Hypercalcemia of malignancy in the palliative care patient: A treatment strategy
9. A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia
10. Gallium nitrate for acute treatment of cancer-related hypercalcemia: A randomized, double-blind comparison to calcitonin
11. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia
12. Comparison of three intravenous bisphosphonates in cancer-associated hypercalcemia